1. 321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer. (9th November 2020) Authors: Gandhi, Shipra; Opyrchal, Mateusz; Ford, Cayla; Fitzpatrick, Victoria; Grimm, Melissa; Basse, Per; Quinn, Marie; Witkiewicz, Agnieszka; Attwood, Kristopher; Ernstoff, Marc; O'Connor, Tracey; Early, Amy; Levine, Ellis; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HER2+ breast cancer. (10th December 2020) Authors: Gandhi, Shipra; Forsyth, Peter; Opyrchal, Mateusz; Ahmed, Kamran; Khong, Hung; Attwood, Kristopher; Levine, Ellis; O'Connor, Tracey; Early, Amy; Fenstermaker, Robert; Prasad, Dheerendra; Takabe, Kazuaki; Czerniecki, Brian; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HER2+ breast cancer. (9th November 2020) Authors: Gandhi, Shipra; Forsyth, Peter; Opyrchal, Mateusz; Ahmed, Kamran; Khong, Hung; Attwood, Kristopher; Levine, Ellis; O'Connor, Tracey; Early, Amy; Fenstermaker, Robert; Prasad, Dheerendra; Takabe, Kazuaki; Czerniecki, Brian; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer. (9th November 2020) Authors: Gandhi, Shipra; Opyrchal, Mateusz; Ford, Cayla; Fitzpatrick, Victoria; Grimm, Melissa; Basse, Per; Quinn, Marie; Witkiewicz, Agnieszka; Attwood, Kristopher; Ernstoff, Marc; O'Connor, Tracey; Early, Amy; Levine, Ellis; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗